CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 60.75% | — | — | |
| 2 | ✓ | Evelo Biosciences INC | Stock-Other | 14.68% | — | — | |
| 3 | DNLI | Denali Therapeutics INC | Stock-Other | 12.82% | — | — | |
| 4 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 6.36% | — | — | |
| 5 | QTRX | Quanterix CORP | Stock-Other | 2.87% | — | — | |
| 6 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 2.52% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QTRX | Quanterix CORP | -2.7% | — | Unchanged |
| 2 | SYRSEUR | Syros Pharmaceuticals INC | -3.8% | — | Unchanged |
| 3 | DNLI | Denali Therapeutics INC | -13.2% | — | Unchanged |
| 4 | MCRB1EUR | Seres Therapeutics INC | -14.5% | — | Unchanged |
| 5 | ✓ | Evelo Biosciences INC | -26.5% | — | Unchanged |
| 6 | RUBYUSD | Rubius Therapeutics INC | — | NEW | New buy |